BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24974755)

  • 1. [PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine].
    Adam Z; Řehák Z; Koukalová R; Bortlíček Z; Krejčí M; Pour L; Szturz P; Prášek J; Nebeský T; Adamová Z; Král Z; Mayer J
    Vnitr Lek; 2014; 60(5-6):499, 501-11. PubMed ID: 24974755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
    Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].
    Adam Z; Sprláková A; Rehák Z; Koukalová R; Szturz P; Krejcí M; Pour L; Zahradová L; Cervinek L; Kren L; Moulis M; Hermanová M; Mechl M; Prásek J; Hájek R; Král Z; Mayer J
    Klin Onkol; 2011; 24(5):367-81. PubMed ID: 22070019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
    Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review].
    Adam Z; Koukalová R; Sprláková A; Rehák Z; Cervinek L; Szturz P; Krejcí M; Pour L; Zahradová L; Moulis M; Prásek J; Chaloupka R; Hájek R; Mayer J
    Vnitr Lek; 2011 Jun; 57(6):576-89. PubMed ID: 21751544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease.
    Goyal G; Shah MV; Call TG; Litzow MR; Hogan WJ; Go RS
    JAMA Oncol; 2017 Sep; 3(9):1253-1256. PubMed ID: 28253394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease].
    Adam Z; Balsíková K; Pour L; Krejcí M; Svacina P; Dufek M; Kren L; Hermanová M; Moulis M; Vanícek J; Neubauer J; Mechl M; Prásek J; Stanícek J; Koukalová R; Hájek R; Mayer J
    Vnitr Lek; 2009 Dec; 55(12):1173-88. PubMed ID: 20070034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pineal gland involvement in Erdheim-Chester disease detected on (18)F-FDG PET-CT imaging: a case report and review of literature.
    Mukherjee A; Dhull VS; Karunanithi S; Sharma P; Durgapal P; Kumar R
    Clin Imaging; 2014; 38(3):367-71. PubMed ID: 24461468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Refractory Erdheim-Chester disease with central nervous system lesion complicated by central diabetes insipidus].
    Yamamoto S; Kasahara I; Yamaguchi K; Sakai T; Wada N
    Rinsho Ketsueki; 2020; 61(10):1476-1481. PubMed ID: 33162443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of 3 patients with Erdhiem-Chester disease with cladribin or cladribin in combination with cyclophosphamide. Case report and review of the therapy.
    Král Z; Řehák Z; Krejčí M; Koukalová R; Ševčíková S; Pour L; Krejčí M; Štork M; Sandecká V; Adam Z
    Vnitr Lek; 2021; 67(3):157-164. PubMed ID: 34171955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erdheim-Chester disease presenting as periodontal disease: Experience of treatment with cladribine, interferon-a, local radiotherapy and anakinra.
    Blomstrand L; Thor A; Hagberg H
    Acta Oncol; 2016; 55(2):248-50. PubMed ID: 25902723
    [No Abstract]   [Full Text] [Related]  

  • 15. [Erdheim-Chester disease: an aggressive systemic disease treated with cladribine with favorable outcome (a case report)].
    Lasri N; Lahlimi F; Tazi MI
    Pan Afr Med J; 2022; 42():32. PubMed ID: 35910054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difficult diagnosis of Erdheim Chester disease revealed by central diabetes insipidus].
    Alaya W; Zantour B; Ben Salem W; Chebbi W; Sfar HM
    Rev Med Liege; 2017 Oct; 72(10):436-438. PubMed ID: 29058834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].
    Valentini D; Cappelli C; Mizzoni F; Noto C; Toscano D; Foco M; Trasimeni G
    Clin Ter; 2004 May; 155(5):205-8. PubMed ID: 15344569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.
    Tamura S; Kawamoto K; Miyoshi H; Suzuki T; Katagiri T; Kasami T; Nemoto H; Miyakoshi S; Kobayashi H; Shibasaki Y; Masuko M; Takeuchi K; Ohshima K; Sone H; Takizawa J
    J Clin Exp Hematop; 2018 Dec; 58(4):161-165. PubMed ID: 30305475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.